Self-supervised learning of wrist-worn daily living accelerometer data improves the automated detection of gait in older adults.

Journal: Scientific reports
PMID:

Abstract

Progressive gait impairment is common among aging adults. Remote phenotyping of gait during daily living has the potential to quantify gait alterations and evaluate the effects of interventions that may prevent disability in the aging population. Here, we developed ElderNet, a self-supervised learning model for gait detection from wrist-worn accelerometer data. Validation involved two diverse cohorts, including over 1000 participants without gait labels, as well as 83 participants with labeled data: older adults with Parkinson's disease, proximal femoral fracture, chronic obstructive pulmonary disease, congestive heart failure, and healthy adults. ElderNet presented high accuracy (96.43 ± 2.27), specificity (98.87 ± 2.15), recall (82.32 ± 11.37), precision (86.69 ± 17.61), and F1 score (82.92 ± 13.39). The suggested method yielded superior performance compared to two state-of-the-art gait detection algorithms, with improved accuracy and F1 score (p < 0.05). In an initial evaluation of construct validity, ElderNet identified differences in estimated daily walking durations across cohorts with different clinical characteristics, such as mobility disability (p < 0.001) and parkinsonism (p < 0.001). The proposed self-supervised method has the potential to serve as a valuable tool for remote phenotyping of gait function during daily living in aging adults, even among those with gait impairments.

Authors

  • Yonatan E Brand
    Department of Biomedical Engineering, Tel Aviv University, Tel Aviv, Israel.
  • Felix Kluge
    Biomedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Luca Palmerini
    Department of Electrical, Electronic, and Information Engineering "Guglielmo Marconi", University of Bologna, 40136 Bologna, Italy.
  • Anisoara Paraschiv-Ionescu
    Laboratory of Movement Analysis and Measurement, Ecole Polytechnique Federale de Lausanne, Lausanne, Switzerland.
  • Clemens Becker
  • Andrea Cereatti
    Information Engineering Unit, POLCOMING Department, University of Sassari, Sassari 07100, Italy. acereatti@uniss.it.
  • Walter Maetzler
    Department of Neurology, Christian-Albrechts-University of Kiel, 24118 Kiel, Germany; Center for Neurology and Hertie Institute for Clinical Brain Research, Department of Neurodegeneration, University of Tuebingen, 72074 Tuebingen, Germany; German Center for Neurodegenerative Diseases (DZNE), 72076 Tuebingen, Germany.
  • Basil Sharrack
    Department of Neuroscience and Sheffield NIHR Translational Neuroscience BRC, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
  • Beatrix Vereijken
    Department of Neuromedicine and Movement Science, Norwegian University of Science and Technology, 7030 Trondheim, Norway.
  • Alison J Yarnall
    Institute of Neuroscience/Institute for Ageing, Newcastle University, Newcastle Upon Tyne NE4 5PL, UK.
  • Lynn Rochester
    Institute of Neuroscience, Newcastle University, Clinical Ageing Research Unit, Campus for Ageing and Vitality, Newcastle upon Tyne, NE4 5PL, UK.
  • Silvia Del Din
  • Arne Muller
    Biomedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Aron S Buchman
    Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, 60612, USA.
  • Jeffrey M Hausdorff
    The Center for the Study of Movement, Cognition and Mobility, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
  • Or Perlman
    Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA, USA. operlman@mgh.harvard.edu.